Czechia· CZ-0268189
VABYSMO
A faricimab product containing faricimab, registered in Czechia by Roche Registration GmbH, Grenzach-Wyhlen. The same ATC class is registered in 14 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Faricimab is registered in 14 of 19 countries.
Countries holding a registration under ATC S01LA09 (faricimab), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 9 of them publish a price we can compare per daily dose
Faricimab · ATC S01LA09
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
SÚKL (Czech Republic)- Active substance
- FARICIMAB
- Manufacturer
- Roche Registration GmbH, Grenzach-Wyhlen
- Country
- Czechia (CZ)
- ATC code
- S01LA09
- ATC class
- Faricimab
- Defined daily dose
- 0.0357 DE, IVT
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 1
1 priced- cz_kod_sukl02681891X0,24ML+1FILTRJCZK 22223.18
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Faricimab in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainVABYSMO 120 MG/ML SOLUCION INYECTABLERoche Registration Gmbh
- SwitzerlandVabysmo 6 mg/0,05 ml, InjektionslösungRoche Pharma (Schweiz) AG
- SwedenVABYSMO 120 mg/ml Injektionsvätska, lösningRoche Registration GmbH
- IrelandVabysmo 120 mg/mL solution for injectionRoche Registration GmbH
- IcelandVabysmoRoche Registration GmbH*
- NorwayVabysmoRoche Registration GmbH
- BelgiumVabysmo 120 mg/mlRoche Registration
- FranceVABYSMO 120 mg/mL, solution injectableROCHE REGISTRATION (ALLEMAGNE)
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Vabysmo
- Liechtenstein · Vabysmo
- Norway · Vabysmo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/66ee551c-33d4-4f61-9cd2-8c0153713476 GET /v1/drugs/66ee551c-33d4-4f61-9cd2-8c0153713476?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "INJ SOL",
"source": "sukl",
"strength": "120MG/ML",
"pack_size": "1X0,24ML+1FILTRJ",
"substance": "FARICIMAB",
"cz_kod_sukl": "0268189",
"product_type": "BT",
"substance_codes": "21764",
"registration_state": "R",
"registration_number": "EU/1/22/1683/001"
}See everything about faricimab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.